Abstract
Introduction
The inherited macular dystrophies are a clinically and genetically heterogeneous group of disorders in which there are structural and functional abnormalities of the central retina [1] , [2] .
These disorders usually occur in isolation, but they may be associated with a variety of systemic abnormalities. All of the Mendelian and mitochondrial inheritance patterns have been described [3] . Most forms of macular dystrophy present in later childhood or in adult life after a period of normal visual development, and are usually progressive. The exception is a rare group of disorders that present with visual impairment in infancy and where there is abnormal foveal or macular development [4] . Such disorders do not commonly progress.
Although most macular dystrophies present with central visual loss, some patients with normal visual acuity are referred to ophthalmologists when a macular abnormality is noted on routine optometric examination. Whatever the mode of presentation, the specific diagnosis is made on the basis of the macular appearance, along with retinal imaging, electrophysiological studies, inheritance patterns and, increasingly, the results of molecular genetic testing [5] .
Some clinical phenotypes do not easily fit into well-characterised disorders.
The present report describes a novel macular phenotype that may occur in isolation, or as a familial trait, which is non-progressive, and which is associated with normal visual function.
Methods

Subjects
Subjects were ascertained based upon the presence of a specific macular phenotype, and were recruited from the pediatric and adult medical retina clinics of three ophthalmologists (one UK, two USA). Informed consent was obtained from all subjects and family members involved in this study. The study had IRB approval from Cincinnati Children's Hospital,
Bascom Palmer Eye Hospital and the Moorfields Eye Hospital Local Research Ethics
Committee, and all investigations were conducted in accordance with the principles of the Declaration of Helsinki.
Clinical Examination
Best-corrected monocular visual acuity (VA) was measured using a logMAR scale and color vision was assessed using Ishihara pseudoisochromatic plates, Hardy Rand Rittler (HRR) color plates and the Farnsworth-Munsell 100 Hue Test. Funduscopy and slit-lamp biomicroscopy were performed. Color fundus photography was undertaken in all subjects; in the majority this was carried out using a Topcon TRC 501A retinal camera (Topcon Corporation, Tokyo, Japan), but in some individuals, seen early in the study period, a Zeiss retinal film camera was used. Spectral domain optical coherence tomography (sd-OCT) using a Heidelberg SPECTRALIS ® Spectral domain OCT scanner (Heidelberg Engineering, Dossenheim, Germany) and fundus autofluorescence (FAF) imaging (Heidelberg Engineering, Dossenheim, Germany) were also performed. Electrophysiological assessment including fullfield electroretinography (ERG), pattern electroretinography (PERG) and Electro-Oculograms (EOG) were performed in the subjects from the UK according to the recommendations of the International Society for Clinical Electrophysiology of Vision (ISCEV) [6] - [7, 8] . Fundus fluorescein angiography was also undertaken in selected subjects.
Genomic analyses
DNA was extracted from whole blood by standard methods. Whole-exome sequencing (WES) was performed for Family 4 (Subjects 8, 9, 11), Moorfields Eye Hospital Genetic Clinic (GC) number GC14302, Family 8 (Subjects 19, 20, 21) and Family 22 (Subject 35), as previously described [9] . Briefly, dsDNA was sheared by sonication to an average size of 200 bp. After nine cycles of PCR amplification using the Clontech Advantage II kit, 1 μg of genomic library was recovered for exome enrichment using the NimbleGen EZ Exome V2 kit. Libraries were sequenced on an Illumina HiSeq2500. Data analysis used the Broad Institute's Genome Analysis Toolkit (GATK) [10] . Reads were aligned with the Illumina Chastity Filter with the Burrows Wheeler Aligner [11] . Variant sites were called using the GATK UnifiedGenotyper module [10] . Variant filtering and group analysis was performed using Qiagen Ingenuity Variant Analysis.
Haplotype sharing analysis was performed on SNP data from 5 affected members of Family 4 genotyped using the Illumina HumanOmniExpress-24 v1.0 beadchip (Illumina, Inc., San Diego, CA, USA) that includes over 715,000 SNPs. Genotypes were determined using the Genotyping Module in the Illumina GenomeStudio v2011.1 software. Build hg19/GRCh37 was used to annotate chromosomal coordinates. The haplotype sharing analysis was carried out using the non-parametric Homozygosity Haplotype (HH) method that searches for chromosomal segments sharing the same haplotype across affected individuals (as an indication of genetic linkage with the disease) [12] . The HH is a type of haplotype described by the homozygous SNPs only (all heterozygous SNPs are removed). Since affected family members who inherited the same mutation from a common ancestor share a chromosomal segment identical-by-descent (IBD) around the disease gene, they should not have discordant homozygous calls in the IBD region and thus they should share the same HH. The HH approach predicts IBD regions through the identification of regions with a conserved HH (RCHHs) defined as those regions with a shared HH among patients and a genetic length longer than a certain cut-off value (recommended cut-off for Illumina array is 2.5/3.0 cM). The median age at presentation was 15 years, range 5-59 years. Twenty-six of 36 subjects were female (Table 1) .
Results
Thirty
Thirty-three subjects (91.7%) were asymptomatic. One subject complained of floaters (Subject 35) but had normal visual acuities and a normal peripheral retinal examination.
Reduced visual acuity was the presenting complaint in the other two symptomatic subjects Refractive error (identified in 15 subjects) was the predominant finding in the 17 subjects who had any past ocular history ( Table 1) . Two of 17 had been treated for strabismus and 3/17 had been treated for amblyopia. One subject developed bilateral optic neuropathy of unknown etiology, during the follow-up period, four and a half years after presentation with the macular phenotype, which resolved spontaneously; and one had non-organic visual loss. General health was good in all, except for Subject 33, who was taking antidepressants.
Visual acuity (VA) at presentation was 0.18 LogMAR or better in both eyes in 30/33 subjects (Table 1) . In 3 subjects the VA was unrecorded (these were all affected family members of probands). Subject 8, with non-organic visual loss, had a presenting VA of 0.78 LogMAR in either eye. Amblyopia affected Subjects 23 (bilateral), 27 (unilateral right eye) and 28
(unilateral left eye) ( Table 1) . Successful amblyopia therapy improved the acuity in Subject 28 to better than 0.18 LogMAR OU. The finding of amblyopia and refractive error in a subset of patients likely reflects the fact that the majority of subjects were ascertained in ophthalmology or optometry clinics. Color vision was normal in 23 of 24 subjects examined, using a variety of color vision tests. Only one subject had mild colour vision abnormalities (Subject 8). She failed two of the HRR screening plates at age 16 years. Anterior segments and ocular mediae were normal in all subjects.
Funduscopy in all subjects revealed characteristic bilateral macular changes consisting of yellow dots at the level of the retinal pigment epithelium (RPE), concentrated around the fovea. These were symmetrical between each eye in all subjects ( Figure 2 ). In the majority of subjects the dots were fine and discrete but in 9 subjects some of the dots were confluent ( Table 2 ). The yellow dots were distributed evenly around the fovea in 13 subjects; in 10 they were concentrated in the nasal parafoveal region. In Subjects 22 and 24 a few additional dots were visible outside the temporal vascular arcades in the right eye. In all but 1 subject (Subject 23) where detailed images were available (26/36), a yellow crescent was visible to varying degrees around the optic disc, which was otherwise normal in all (Table 2, Figure 2 ).
The retinal periphery and vasculature were otherwise normal in all subjects. Funduscopy was normal in all parents of the sporadic cases that were examined.
Fundus autofluorescence imaging, available for 22/36 subjects, revealed foci of hyperautofluorescence corresponding to the yellow dots on otherwise normal background autofluorescence ( Figure 3) . The autofluorescence imaging did not reveal any lesions other than those visible on funduscopy.
Sd-OCT imaging was performed in 18 subjects and was normal in 11. There was minimal irregularity of the inner segment ellipsoid (ISe) band in 6 subjects ( Subjects 11, 14, 16, 17, 23, 26) , corresponding to the locations of the yellow dots, as observed on the infrared reflectance image (Figure 4) . In one additional subject the only change seen on OCT imaging was a mild irregularity of the RPE layer (Subject 28).
Electroretinography was performed in 19 subjects. The ERG was normal in all 19 subjects, and the PERG was abnormal in 2. There was a mildly subnormal PERG P50 component amplitude in subject 4. In Subject 28 the PERG was moderately subnormal in each eye, indicative of moderate macular dysfunction. EOGs in 9 of 10 subjects demonstrated a normal light rise. In Subject 28 the EOG was of poor technical quality, which precluded accurate quantification of the light rise. and MCDR3 locus on chromosome 5, no rare variants were found to consistently segregate with the macular phenotype in any of the known retinal disease genes. Additionally, genelevel analysis did not detect exonic or splice site variants in the same gene for two or more families. Therefore, non-coding causes were predicted as a common mechanism, as has been reported for MCDR1 and MCDR3 [13, 14] . Genome-wide analysis was performed for family 4 using SNP chips. A search for a shared IBD chromosomal segment among the five affected individuals with SNP chip data in family 4 (GC14302) was performed using the HH method. The haplotype sharing analysis revealed no evidence of linkage at the MCDR1 locus (Supplementary Table 1 Many different inherited disorders are associated with 'deposits' at the macula. However, they may be distinguished from the phenotype described here by the age of onset, associated visual loss, disease progression, retinal electrophysiology and results of OCT imaging. A similar non-progressive retinal phenotype with drusenoid deposits that are present from childhood can be seen in North Carolina Macular Dystrophy (NCMD), a dominantly inherited macular dystrophy which has been mapped to chromosome 6q16 (MCDR1 locus) [15] . The ERG and EOG are also normal in NCMD, with dysfunction being confined to the macula.
Recently, Small et al. identified rare variants upstream of the retinal transcription factor gene
PRDM13 in families with NCMD that link to the MCDR1 locus [14] . An identical phenotype has been mapped to chromosome 5p15 (MCDR3 locus) [16] , [17] . Although the disorder reported here is also of early onset, is non-progressive and is associated with a normal ERG and EOG, there are a number of differences between the two. There may be considerable phenotypic heterogeneity in NCMD, with some family members having normal visual acuity with drusen-like deposits, whilst others have large ectatic macular lesions causing central visual loss. Furthermore, there is generally a family history consistent with an autosomal dominant inheritance pattern. Most of the present cases were sporadic or from small families.
Those family members of sporadic cases who were examined had normal fundi. WES in 7 subjects failed to reveal any mutations in known retinal dystrophy genes, and SNP-based haplotype sharing analysis excluded linkage to the MCDR1 locus and a portion of the MCDR3 locus, adding support to the hypothesis that this is a new macular condition. Further molecular analysis is required to determine the etiology.
Drusen-like deposits at the macula may be seen in children and young adults in a variety of ocular and syndromic disorders (for review see Khan et al 2016) [18] . Small yellow deposits may be present in the early stages of the macular dystrophy associated with mutations in PRPH2, but the macular abnormalities, which are rarely seen before teenage years, are progressive and are often associated with full-field ERG abnormalities, particularly in late disease [19, 20] . Macular drusen are seen in autosomal dominant drusen but again, those have a later age of onset, a different retinal distribution and a different appearance on retinal imaging [21] [22] [23] . Drusen-like deposits at the macula have also been reported in systemic disorders such as mesangioproliferative glomerulonephritis type 2 and lipodystrophy, but in those disorders the drusen are larger, more extensive and increase in number with age [24] - [25, 26] . Similar macular deposits have been reported in association with other systemic findings in individuals with ring chromosome 17 and trisomy 10q [27] [28] [29] [30] . However, none of the present subjects had any relevant systemic abnormalities.
The affected individuals in the present study were identified at routine optometric visits or by examination of other affected family members. Visual acuity was normal in the majority, and in all but one subject this was accompanied by normal electroretinographic findings that investigated both the detailed macular function (PERG) and global retinal function (ERG).
Although no significant longitudinal data are available, none of the subjects showed progression over time, and the similarity of fundus appearance across generations in familial cases suggests the phenotype to be non-progressive. The novel macular phenotype described here has a characteristic appearance on fundus examination and retinal imaging. However in order to exclude other disorders with a similar appearance early in the disease process, it is important to demonstrate normal retinal function. Investigations should include a full-field ERG and pattern ERG or multifocal ERG.
OCT is also useful to exclude other phenotypes with drusen-like deposits [18] . The major differential diagnosis is from NCMD, where there is also a normal ERG, but examination of other family members should allow this disorder to be excluded.
To conclude, a novel childhood onset macular phenotype is described in which there are multiple yellow dots at the macula associated with normal macular function. The condition is of early onset and may be developmental in origin; it appears to be distinct from other developmental macular dystrophies. The yellow dots are hyperautofluorescent on FAF imaging and may show subtle irregularities at the inner segment ellipsoid band on OCT imaging. Such a phenotype has not, to our knowledge, been previously reported. Affected individuals can be reassured that the condition is benign and unlikely to be associated with any significant visual loss. 
